<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>allen &amp; overy - Le Fonti New Pharma Italy</title>
	<atom:link href="https://www.newpharmaitaly.it/tag/allen-overy/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.newpharmaitaly.it/tag/allen-overy/</link>
	<description>Il portale delle news in ambito farmaceutico</description>
	<lastBuildDate>Tue, 21 Jul 2020 07:01:13 +0000</lastBuildDate>
	<language>it-IT</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.newpharmaitaly.it/wp-content/uploads/2022/12/cropped-favicon-new-pharma-italy-32x32.jpg</url>
	<title>allen &amp; overy - Le Fonti New Pharma Italy</title>
	<link>https://www.newpharmaitaly.it/tag/allen-overy/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>AV-Comparatives Releases Long-term Enterprise Antivirus Test Report for 19 Leading Endpoint Security Solutions </title>
		<link>https://www.newpharmaitaly.it/av-comparatives-releases-long-term-enterprise-antivirus-test-report-for-19-leading-endpoint-security-solutions/</link>
					<comments>https://www.newpharmaitaly.it/av-comparatives-releases-long-term-enterprise-antivirus-test-report-for-19-leading-endpoint-security-solutions/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Tue, 21 Jul 2020 07:01:13 +0000</pubDate>
				<category><![CDATA[Immedia press]]></category>
		<category><![CDATA[allen & overy]]></category>
		<category><![CDATA[aviva]]></category>
		<category><![CDATA[cessione]]></category>
		<category><![CDATA[ubi]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/immediapress/ict/2020/07/21/comparatives-releases-long-term-enterprise-antivirus-test-report-for-leading-endpoint-security-solutions_QqO2403TuovP11sourxkbN.html</guid>

					<description><![CDATA[<p>Most comprehensive comparative report on business and enterprise endpoint security solutions published INNSBRUCK, Austria, July 21, 2020 /PRNewswire/ -- Independent, ISO-certified security testing lab AV-Comparatives has released its July 2020 Business Security Test Report. It is the most comprehensive comparative report of...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/av-comparatives-releases-long-term-enterprise-antivirus-test-report-for-19-leading-endpoint-security-solutions/">AV-Comparatives Releases Long-term Enterprise Antivirus Test Report for 19 Leading Endpoint Security Solutions </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/av-comparatives-releases-long-term-enterprise-antivirus-test-report-for-19-leading-endpoint-security-solutions/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Sunport Power Optimizes S6 Flexible Module, Aiming Growing BIPV Market </title>
		<link>https://www.newpharmaitaly.it/sunport-power-optimizes-s6-flexible-module-aiming-growing-bipv-market/</link>
					<comments>https://www.newpharmaitaly.it/sunport-power-optimizes-s6-flexible-module-aiming-growing-bipv-market/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Mon, 13 Jul 2020 05:45:35 +0000</pubDate>
				<category><![CDATA[Immedia press]]></category>
		<category><![CDATA[allen & overy]]></category>
		<category><![CDATA[cartolarizzazione]]></category>
		<category><![CDATA[STS]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/immediapress/ambiente/2020/07/13/sunport-power-optimizes-flexible-module-aiming-growing-bipv-market_HfP9uN8mKEubiOs5AS1qSO.html</guid>

					<description><![CDATA[<p>WUXI, China, July 13, 2020 /PRNewswire/ -- The world's first manufacturer on GW-scale for MWT PV module, Sunport Power announced recently that the company has optimized the S6 flexible module product which aims the growing BIPV market.  Being launched in 2018...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/sunport-power-optimizes-s6-flexible-module-aiming-growing-bipv-market/">Sunport Power Optimizes S6 Flexible Module, Aiming Growing BIPV Market </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/sunport-power-optimizes-s6-flexible-module-aiming-growing-bipv-market/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Speranza: &#8220;Divieto d&#8217;ingresso per chi arriva da Paesi a rischio&#8221; </title>
		<link>https://www.newpharmaitaly.it/speranza-divieto-dingresso-per-chi-arriva-da-paesi-a-rischio/</link>
					<comments>https://www.newpharmaitaly.it/speranza-divieto-dingresso-per-chi-arriva-da-paesi-a-rischio/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Thu, 09 Jul 2020 14:29:48 +0000</pubDate>
				<category><![CDATA[Attualità]]></category>
		<category><![CDATA[allen & overy]]></category>
		<category><![CDATA[cessione]]></category>
		<category><![CDATA[omav]]></category>
		<category><![CDATA[sms group]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/fatti/cronaca/2020/07/09/fase-speranza-divieto-ingresso-per-chi-arriva-paesi-rischio-covid_UbgOGldG3klxzSQfZg34PI.html</guid>

					<description><![CDATA[<p>Divieto di ingresso in Italia per chi arriva da Paesi a rischio Covid. Lo prevede l'ordinanza firmata oggi dal ministro della Salute, Roberto Speranza, sentiti i ministri degli Affari Esteri, dell’Interno e dei Trasporti. L'ordinanza dispone il "divieto di ingresso e...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/speranza-divieto-dingresso-per-chi-arriva-da-paesi-a-rischio/">Speranza: &#8220;Divieto d&#8217;ingresso per chi arriva da Paesi a rischio&#8221; </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/speranza-divieto-dingresso-per-chi-arriva-da-paesi-a-rischio/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>CEC: Zambian Government Moves to Expropriate CEC Power Infrastructure </title>
		<link>https://www.newpharmaitaly.it/cec-zambian-government-moves-to-expropriate-cec-power-infrastructure/</link>
					<comments>https://www.newpharmaitaly.it/cec-zambian-government-moves-to-expropriate-cec-power-infrastructure/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Wed, 03 Jun 2020 14:37:20 +0000</pubDate>
				<category><![CDATA[Immedia press]]></category>
		<category><![CDATA[allen & overy]]></category>
		<category><![CDATA[bond]]></category>
		<category><![CDATA[capital markets]]></category>
		<category><![CDATA[FCA Bank]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/immediapress/energia/2020/06/03/cec-zambian-government-moves-expropriate-cec-power-infrastructure_Ydi1emaAjzkn7awQv6rTnL.html</guid>

					<description><![CDATA[<p>LUSAKA, Zambia, June 3, 2020 /PRNewswire/ -- The Copperbelt Energy Corporation Plc (CEC) has become aware of Statutory Instrument No. 57 of 2020 (SI 57) issued by the Minister of Energy, Honourable Mathew Nkhuwa, declaring all of CEC's distribution and transmission...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/cec-zambian-government-moves-to-expropriate-cec-power-infrastructure/">CEC: Zambian Government Moves to Expropriate CEC Power Infrastructure </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/cec-zambian-government-moves-to-expropriate-cec-power-infrastructure/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
